Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone

By Setiawan Elaine   Pihl Robert O   Benkelfat Chawki   Leyton Marco  

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1161-1172

Future Medicine

Access to resources Recommend Favorite

The association between naltrexone treatment and symptoms of depression in opioid-dependent patients

By Mysels David J.   Cheng Wendy Y.   Nunes Edward V.   Sullivan Maria A.  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 1, 2011-01 ,pp. : 22-26

Informa Healthcare

Access to resources Recommend Favorite

Safety and Efficacy of Baclofen in the Treatment of Alcohol-Dependent Patients

By  

Current Pharmaceutical Design, Vol. 16, Iss. 19, 2010-06 ,pp. : 2113-2117

Bentham Science Publishers

Access to resources Recommend Favorite

Naltrexone (50 mg) Plus Psychotherapy in Alcohol-Dependent Patients: A Meta-Analysis of Randomized Controlled Trials

By Jarosz Joanna  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 3, 2013-05 ,pp. : 144-160

Informa Healthcare

Access to resources Recommend Favorite

µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain

By Walter Carmen   Doehring Alexandra   Oertel Bruno G   Lötsch Jörn  

Pharmacogenomics, Vol. 14, Iss. 15, 2013-11 ,pp. : 1915-1925

Future Medicine

Access to resources Recommend Favorite